Percutaneous post

The Defibrillator in Acute Myocardial Infarction Trial (DINAMIT) enrolled nearly 700 patients with recent MI, ranging from 6 to 40 days (median 7 days), EF < 36%, and reduced heart rate variability but without NYHA class IV symptoms, sustained VT within 48 h of MI, or surgical or percutaneous 3-vessel revascularization [34]. Patients were randomized to ICD therapy versus conventional therapy and at 1 year, there was no difference in total mortality with more arrhythmic deaths in the control arm and more nonarrhythmic deaths in the ICD arm. Thus, there appears to be no benefit to ICD therapy in the immediate post-MI period. An interpretation of the negative result of both of these trials is that significant recovery of LV function may have occurred in the... 

Siminiak T, Fiszer D, Jerzykowska O, Grygielska B, Rozwadowska N, Kalmucki P, Kurpisz M. Percutaneous trans-coronary-venous transplantation of autologous skeletal myoblasts in the treatment of post-infarction myocardial contractility impairment the POZNAN trial. Eur i/eart / 2005 26 1188-1195. 

A 1-year study of the FibroPlant system in a mixed population of 141 peri- and post-menopausal women, including women with heavy or post-menopausal bleeding and women needing contraception, was too small and too heterogeneous to justify firm conclusions, and most of the women were in any case also using percutaneous 17-beta-estradiol 1.5 mg/day) (49). However, the results suggested that this regimen is well tolerated. 

Gibson CM, Morrow DA, Murphy SA, et al. A randomized trial to evaluate the relative protection against post-percutaneous coronary intervention microvascular dysfunction, ischemia and inflammation among antiplatelet and antithrombotic agents. The PROTECT-TIMI-30 trial. J Am Coll Cardiol 2006 47 2364-2373. 

Post laser atherectomy and percutaneous transluminal angioplasty of popliteal artery as well as tibioperoneal trunk, IV heparin used as an anticoagulant with pretreatment with aspirin and clopidogreh... 

Benton et al. (2006b, 2007) experimentally determined the LCtso and LC50 in male and female adult SD rats exposed whole body to VX vapor for 10, 60, and 240 min in a dynamic exposure chamber (Table 6.3) study protocol was similar to that for agent GB in the studies conducted by Mioduszewski et al. (2001, 2002a). Experiments testing the role of decontamination less than 24 h post-exposure provided clear evidence for percutaneous toxicity induced by whole-body vapor exposure to the persistent nerve agent VX. For severe and lethal VX vapor exposure effects, females were not more susceptible than males for the exposure durations examined. 

Intramuscular 3 subjects Oral (4.25 - 4.5 Mg/kg) 3 subjects Percutaneous (5.0 - 45 iig/kg) 10 subjects The vast majority of these subjects reportedly experienced little or no effect from the drug. In 2 cases, the cholinesterase (RBC) level was less that 20% of normal In subjects that received multiple doses, but in each case the dosing was stopped and the cholinesterase levels returned to normal limits within 6-7 days post exposure. No visible effects of the drug were observed In any of these subjects. One subject (A2(BN)) received 30 ug/kg, percutaneously, showed some effects (headache, nausea, Q)E 15% of normal, nervous) and was treated with multiple doses of atropine and... 

BZ (7.4 - 14.5 pg/kg) aerosol Inhalation, 2 subjects 3834 (2 0 mg) percutaneous, 1 subject Atropine (125 pg/kg) Intramuscular, 3 subjects Prolixin (15.0 - 23.0 pg/kg) Intramuscular, 6 subjects 302668 (10.0 pg/kg) Intravenous, 1 subject 302196 (75.6 Pg/kg) oral, 1 subject TAB (90 mg total) Intramuscular, 1 subject Pretreatment with methyl scopolamine (1.0 mg) 1 subject Only 2 subjects (AlOJ) and (AlOK) who received doses of BZ and were subsequently treated with physostlgmine, showed any prolonged central effects (hallucinations, disorientation, confusion) lasting 4 to 6 days post >exposure Both subjects were asymptomatic and appeared normal when discharged from test. One subject (AlCM)) was exposed to Prolixin (23.0 pg/kg) and then treated with multiple doses (1.0 mg X 7 doses) over a 2 ay period, intramuscularly At 27 hours post-exposure, the subject complained of blurred vision, and facial expression was mask-llke, tongue "thick" and jaws open. 

Endothelin has been implicated in myocardial infarction, coronary vasospasm and re-stenosis subsequent to percutaneous transluminal coronary angioplasty. The potent, prolonged coronary vasoconstrictor and mitogenic actions of endothelin are well-documented (see earlier section) and thus endothelin is certainly able to produce the biological effects seen in these disease states. Although a reduction in infarct size has been demonstrated in a rat model of myocardial infarction with an endothelin antibody [185], and with phosphoramidon [186], the argument for a role for endothelin in ischaemic heart disease has been based mainly on the finding of increased plasma endothelin levels in patients with myocardial infarction [187-190], coronary vasospasm [191, 192] and re-stenosis post-PTCA [193-195]. 

Following an occupational exposure, it is vital that healthcare workers are cognizant of institutional policies and procedures to allow for the timely and organized collection of data and initiation of post-exposure prophylaxis if indicated. Institutions must have policies and procedures in place to react quickly to occupational exposure to avoid unnecessary delays in therapy. The date and time, details pertaining to the type of activity being performed, nature of the exposure (type, amount, severity, percutaneous, mucous membrane, time of contact, condition of skin), and details about the source (HIV infected, viral load, history of antiretroviral therapy) should be recorded in the healthcare worker s medical record. It is recommended that skin sites or wounds that are contaminated should be washed with soap and water. The use of antiseptics may be considered, but application of caustic substances such as bleach is not recommended, as this would compromise the integrity of the skin barrier. Mucous membranes should be flushed extensively with water. 

Each occupational exposure needs to be considered on 7. a case-by-case basis. The risk of occupational HIV transmission appears to be greatest if the exposure is percutaneous in nature. In order to optimize post-exposure prophylaxis, the duration between exposure and initiation of therapy must be kept at a minimum preferably within a few hours. Despite the concern of viral resistance, postexposure prophylaxis regimens should include 4 weeks of zidovudine plus lamivudine, and under certain circum- 9, stances, a protease inhibitor. 

Clearly the post-absorption differential distribution of CN to the various systemic tissues will determine the relative proportions of CN present at detoxification and target tissue/cell sites. Thus, inhaled or percutaneously absorbed... 

Magnetic resonance cholangiography (MRCP) T2-weighted sequences provide an evaluation of the intra- and extrahepatic bile ducts. Other sequences such as a T1 post-contrast injection provide fine detail on the periportal spaces, parenchyma, and blood vessels. Visualization of the entire biliary tree and the choledochal cysts using MRCP has been reported (Krause et al. 2002). MRCP provides information for the operative planning with less potential risks than ERCP or percutaneous transcutaneous cannulation (PTC). 

The need for biliary drainage in children is less frequent than in adults however, there are a number of indications for performing a percutaneous tran-shepatic cholangiogram (PTC) (Diament et al. 1985). The most common indications for PTC is obstructive jaundice resulting from either a malignancy, most commonly rhabdomyosarcoma of the bile ducts or pancreas and neuroblastoma, or post liver transplantation. Cholithiasis is less frequently a causative agent (Lorenz et al. 2001 Roebuck and Stanley 2000 Rose et al. 2001). Cholangitis, which is a relatively common indication for PTC in adults, is rarely seen in children. 

Includes, e.g., post-coronary artery bypass graft, post-percutaneous transluminal coronary angioplasty, unstable angina. 

Puri S, Nicholson AA, Breen DJ (2003) Percutaneous thrombin injection for the treatment of a post-pancreatitis pseudoaneurysm. Eur Radiol 13 L79-L82... 

When the percutaneous procedure is compared to surgical ligation, varicocele embolization has been shown to be an equally effective means of treatment and is associated with less post procedure discomfort and more rapid return to normal activities [24, 36-38]. 

Ravandi A, Harkewicz R, Leibundgut G. Identification of oxidized phospholipids and cholesteryl esters in embolic protection devices post percutaneous coronary, carotid and peripheral interventions in humans (abstr). Arteriosclerosis, Thrombosis, and Vascular Biology, Scientific Sessions. April 28-30, 2011 Chicago, IL. 

Fig. 18.18. a,b AP and lateral radiographs of radial neck fracture displaced by reduction of the dislocated elbow. Radial head lies adjacent to the capitellum. c Intraoperative radiographs showing intramedullary nancy nail and percutaneous wire used to manipulate the femoral head, d Post reduction film... 

In 2002, Dong et al. (2003) published a study on MW ablation in a large cohort of 234 patients with 339 HCC lesions treated via MW coagulation therapy with up to 5-year survival rates. Percutaneous interventional treatment was performed with ultrasonographic applicator guidance. A 89.3% rate of technically complete ablations was reported, with a lack of enhancing residual tumor tissue in immediate follow-up CT or MR scan. In 194 nodules, additional post-treatment biopsies were carried out with an absence of viable tumor cells in 180 nodules (92.8%). The 3-year survival rate was 72.9%, the 5-year survival rate 56.7%. No clinical reports have been published so far for the 915-MHz device. 

---